Amrutajan Health Share Price

Amrutajan Health Share Price

NSE: AMRUTANJAN
|
Pharmaceuticals
|
S Cap
₹ 510.05
+₹10.00 (2.00%)
1D
Last updated 23 Sep, 2026, 15:59 IST

Amrutajan Health Share Price Today

As of 23 Sep 2026, Amrutajan Health share price is ₹510.05. The stock opened at ₹500.05, compared to its previous close of ₹500.05. During today's trading session, Amrutajan Health share price moved in the range of ₹498.00 to ₹513.35, with an average price of ₹505.68 for the day. Looking at its last 52-week, the stock has touched a low of ₹476.50 and a high of ₹772.00. On the performance front, Amrutajan Health share price has declined by 1.45% over the last six months and is down 32.66% on a year-on-year basis.

₹498.00
2.00% up today
₹513.35
1D LOW
1D HIGH

Amrutajan Health Returns Calculator

Circuit
L
H
₹400.05
₹600.05
52-week
L
H
₹476.50
₹772.00

About Amrutajan Health

Amrutajan Health Share Price
ISIN
INE098F01031
Sector Market Cap
₹ 1,446.25 Cr

Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene and services in pain management. Its segments include OTC Products, Women Hygiene, Beverages and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Women Hygiene includes Comfy Snug Fit, Comfy Snug Fit Extra Long, and Comfy Snug Fit Ultra XL. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Company’s pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint.

Amrutajan Health Financial Highlights

  • Revenue: Amrutajan Health reported revenue of ₹228.81 crore in FY17 vs ₹192.42 crore in FY16. It showed an increase of 18.91% on a yearly basis.
  • Operating Profit: Amrutajan Health reported an operating profit of ₹33.24 crore in FY17 vs ₹32.68 crore in FY16. It showed an increase of 1.71% on a year-on-year basis.
  • Net Profit: Amrutajan Health reported a net profit of ₹21.14 crore in FY17 vs ₹20.58 crore in FY16. It showed an increase of 2.72% on a yearly basis.

Amrutajan Health Quarterly Result Highlights

  • Amrutajan Health reported revenue of ₹106.78 crore in Jun 2026, compared with ₹154.50 crore in Mar 2026, representing a decrease of 30.89% on a quarter-on-quarter (QoQ) basis.
  • Amrutajan Health reported an operating profit of ₹6.07 crore in Jun 2026, compared with ₹21.02 crore in Mar 2026, representing a decrease of 71.12% on a quarter-on-quarter (QoQ) basis.
  • Amrutajan Health reported a profit of ₹4.37 crore in Jun 2026, compared with ₹16.19 crore in Mar 2026, reflecting a decrease of 73.01% on a QoQ basis.
  • The earnings per share (EPS) of Amrutajan Health stood at ₹20.03 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
46.52%
FII
2.44%
Other DII
6.46%
Retail and other
38.76%
Mutual funds
5.82%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20252.38%
Dec 20252.27%
Mar 20262.17%
Jun 20262.44%
Mkt Cap Cr
609.90
P/E
26.79
P/B
3.91
ROE
17.42%
D/E
0.00
ROCE
23.31%
Div. Yield
0.98%
EPS(TTM)
20.03
Turnover
1.01
EV/EBITDA
17.63
Net Margin
12.77%
Op. Margin
18.57%
ROA
10.61%
Quick Ratio
2.02
Curr. Ratio
2.32
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Amrutanjan Healt has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Amrutanjan Healt appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Amrutanjan Healt earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Amrutajan Health Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2016Mar 2015Mar 2014Mar 2013
Revenue₹186.74₹166.57₹141.73₹137.65
Other Income₹5.68₹4.48₹2.94₹4.27
Total Revenue₹192.42₹171.04₹144.67₹141.92
Total Expenses₹159.74₹146.90₹125.29₹126.44
Profit Before Tax₹32.45₹24.15₹19.38₹15.47
Tax₹11.87₹9.25₹6.94₹5.36
Profit After Tax₹20.58₹14.90₹12.44₹10.12
EPS - Basic₹14.08₹10.31₹8.51₹6.92
EPS - Diluted₹14.08₹10.31₹8.51₹6.92

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2016Mar 2015Mar 2014Mar 2013
Profit before tax₹32.68₹24.15₹19.38₹15.47
Income before WC changes₹31.38₹24.48₹22.89₹18.53
Change in Assets-₹5.47-₹0.63₹5.57-₹6.30
Change in Liabilities₹6.28₹3.84-₹3.66₹1.92
Change in WC₹0.81₹3.22₹1.91-₹4.38
Cash flow from Operations₹20.70₹18.32₹17.45₹8.62
Cash flow from Investing₹4.16-₹4.89₹16.49₹7.73
Cash flow from Financing-₹13.10-₹11.93-₹13.92-₹14.26
Total Cash Flow₹11.76₹1.49₹20.02₹2.09
Cash (Start of the year)₹30.67₹29.17₹9.15₹7.06
Cash (End of the year)₹42.42₹30.67₹29.17₹14.91

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2016Mar 2015Mar 2014Mar 2013
Non-Current Assets₹39.95₹41.06₹42.02₹60.78
Current Assets₹100.49₹82.84₹78.25₹63.38
Total Assets₹140.44₹123.90₹120.27₹124.16
Current Liabilities₹27.98₹25.85₹27.25₹37.99
Net Current Asset₹72.52₹56.98₹51.00₹25.39
Non-Current Liabilities₹3.72₹3.10₹3.78₹3.90
Equity Capital₹108.74₹94.95₹89.24₹82.27
Total Equity & Liabilities₹140.44₹123.90₹120.27₹124.16

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹502.55₹451.82₹421.23₹379.64
Other Income₹17.57₹17.68₹16.35₹14.54
Total Revenue₹520.13₹469.50₹437.58₹394.18
Total Expenses₹433.38₹400.36₹375.63₹340.53
Profit Before Tax₹77.89₹69.13₹61.95₹53.65
Tax₹19.97₹18.30₹16.97₹13.81
Profit After Tax₹57.92₹50.83₹44.97₹39.83
EPS - Basic₹20.03₹17.58₹15.50₹13.63
EPS - Diluted₹20.03₹17.58₹15.50₹13.63

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹77.89₹69.13₹61.95₹53.65
Income before WC changes₹67.21₹59.80₹54.60₹45.88
Change in Assets-₹25.39-₹7.41-₹19.41₹2.17
Change in Liabilities₹13.17₹16.43₹9.23-₹11.81
Change in WC-₹12.21₹9.02-₹10.19-₹9.64
Cash flow from Operations₹35.97₹50.90₹27.91₹20.18
Cash flow from Investing-₹21.23-₹30.97₹19.17-₹2.48
Cash flow from Financing-₹13.62-₹13.49-₹48.27-₹14.99
Total Cash Flow₹1.12₹6.44-₹1.19₹2.72
Cash (Start of the year)₹10.16₹3.71₹4.90₹2.19
Cash (End of the year)₹11.27₹10.16₹3.71₹4.90

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹217.24₹130.72₹71.19₹102.15
Current Assets₹291.65₹290.67₹295.68₹259.95
Total Assets₹508.89₹421.39₹366.87₹362.09
Current Liabilities₹126.18₹84.58₹69.92₹63.01
Net Current Asset₹165.46₹206.09₹225.76₹196.94
Non-Current Liabilities₹12.47₹10.19₹8.46₹8.31
Equity Capital₹370.23₹326.61₹288.49₹290.77
Total Equity & Liabilities₹508.89₹421.39₹366.87₹362.09
* All values are in INR Crore
Qty
Bid
3
510.05
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 3
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
3
Neutral
5
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
47.26
Neutral
ATR (14)
12.09
Neutral
STOCH(9,6)
66.34
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
22.73
Bearish
UO(9)
56.45
Neutral
ROC(12)
-1.44
Bearish
WillR(14)
-40.38
Neutral
Period
Simple value
Exponential vaue
5D
494.26
495.98
10D
494.96
496.64
20D
502.64
500.65
50D
512.23
512.07
100D
531.74
527.29
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Amrutajan Health Share Price
Amrutajan Health
Pharmaceuticals
Add Stock
Add Another

Amrutajan Health Share Price FAQs

Amrutajan Health share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837